Perfluoro-n-octane (PFO) is a dense liquid (specific gravity of 1.76) that is used for the intraoperative management of retinal detachments. Due to its density, low viscosity, and immiscibility in water, the PFO is able to displace sub-retinal fluid and blood anteriorly, allowing for retinal unfolding and stabilization during repair. PFO has been observed to be safe and effective in the ...
67-year-old male with subretinal perfluoro-N-octane (PFO) bubbles after incomplete PFO removal during retinal detachment repair at an outside facility. The patient was symptomatic with decreased visual acuity, metamorphopsias, and small central and paracentral scotomata. PFO is a heavy liquid used to flatten the retina during vitreoretinal surgery, and it should be removed intraoperatively to ...
Cardiogenic embolic sources most commonly result from atrial fibrillation, but can also be caused by valvular disease, dilated cardiomyopathy, left atrial or ventricular thrombus, patent foramen ovale (PFO), or congestive heart failure (4). Signs/Symptoms Unilateral occipital strokes most commonly present with contralateral homonymous hemianopia.
Perfluoro-n-octane in the Anterior Chamber ... This 26 year-old man has Marfan syndrome and had bilateral pars plana vitrectomy, lensectomy with anterior chamber intraocular lenses. Perfluoro-n-octane (PFO)was used during his vitrectomy and one can see the silicone oil in the anterior chamber at the haptic of the intraocular lens.
Marco R. Di Tullio; Peter C. Block, M.D., F.A.C.C. However, the risk of first-ever stroke in asymptomatic subjects with PFO in the general population has not been clearly established. This information ...
Patent foramen ovale (PFO) is the most common congenital heart abnormality of fetal origin and is present in approximately ∼25% of the worldwide adult population. PFO is the consequence of failed ...